Clinical Trials Directory

Trials / Completed

CompletedNCT03139292

Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway

Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway in Spontaneously Breathing Patients Undergoing Elective Surgery Under General Anaesthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Tata Main Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Comparison of two different supraglottic airway devices i.e., the ProSeal Laryngeal Mask Airway (PLMA) and Ambu AuraGain, a third generation laryngeal mask Airway.

Detailed description

The study aims to compare the two devices with respect to: Time taken for insertion. Insertion attempts or failed attempt. Oropharyngeal leak pressure Air leak Time taken to pass an orogastric tube Attempts to pass an orogastric tube or failed attempt. Haemodynamic variation Incidence of adverse events like failed insertion, aspiration-regurgitation, hypoxia (SpO2\< 90%), bronchospasm, airway obstruction, gastric insufflation, coughing, gagging, retching, hiccup, coughing during removal, blood staining of the airway device and trauma to tongue, lip, teeth, or gums.

Conditions

Interventions

TypeNameDescription
DEVICEProSeal Laryngeal Mask AirwayProSeal Laryngeal Mask Airway was used as the supraglottic device
DEVICEAmbuAuraGain Laryngeal Mask AirwayAmbuAuraGain Laryngeal Mask Airway was used as the supraglottic device

Timeline

Start date
2016-05-01
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2017-05-03
Last updated
2019-12-30

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03139292. Inclusion in this directory is not an endorsement.